相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。De novo acute myeloid leukemia: A population- based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017
Koji Sasaki et al.
CANCER (2021)
Impact of insurance status on the survival of younger patients diagnosed with acute promyelocytic leukemia in the United States
Omer H. Jamy et al.
CANCER (2021)
Oral arsenic trioxide ORH-2014 pharmacokinetic and safety profile in patients with advanced hematologic disorders
Farhad Ravandi et al.
HAEMATOLOGICA (2020)
Oral arsenic trioxide, all-trans retinoic acid, and ascorbic acid maintenance after first complete remission in acute promyelocytic leukemia: Long-term results and unique prognostic indicators
Harinder S. Gill et al.
CANCER (2020)
A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with high-risk APL (SWOG 0535)
Jeffrey E. Lancet et al.
BLOOD ADVANCES (2020)
Poor Treatment Outcomes of Young (<60 Years) African American Patients (Pts) Diagnosed with Acute Myeloid Leukemia (AML) (Alliance)
Bhavana Bhatnagar et al.
BLOOD (2020)
The factors affecting early death in newly diagnosed APL patients
Rafiye Ciftciler et al.
OPEN MEDICINE (2019)
Complications and early mortality in patients with acute promyelocytic leukemia treated in California
Gwendolyn Ho et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab
Yasmin Abaza et al.
BLOOD (2017)
Improved OutcomesWith Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial
Uwe Platzbecker et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Early death rates remain high in high-risk APL: update from the Swedish Acute Leukemia Registry 1997-2013
S. Lehmann et al.
LEUKEMIA (2017)
Targeted Therapy Alone for Acute Promyelocytic Leukemia
Francesco Lo-Coco et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Early Mortality in Patients with Acute Promyelocytic Leukemia (APL) Treated in Teaching Versus Non-Teaching Hospitals
Adam Levin et al.
BLOOD (2016)
Disparities in early death and survival in children, adolescents, and young adults with acute promyelocytic leukemia in California
Renata Abrahao et al.
CANCER (2015)
Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial
Alan K. Burnett et al.
LANCET ONCOLOGY (2015)
Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL
Eduardo M. Rego et al.
BLOOD (2013)
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
F. Lo-Coco et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007
Graca M. Dores et al.
BLOOD (2012)
Acute promyelocytic leukemia: A population-based study on incidence and survival in the United States, 1975-2008
Yiming Chen et al.
CANCER (2012)
Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid
Jae H. Park et al.
BLOOD (2011)
Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002
Jennifer F. Yamamoto et al.
CANCER CAUSES & CONTROL (2008)
分享论文
